Hanapi, Alra-ib D.
HRN: 27-27-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
CEFUROXIME 750MG (VIAL)
06/22/2026
06/29/2026
IV
260
Q8
AGE
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: